Understanding Reasons for Nonadherence to Medications in a Medicare Part D Beneficiary Sample

被引:8
|
作者
Hincapie, Ana L. [1 ]
Taylor, Ann M. [2 ]
Boesen, Kevin P. [4 ]
Warholalk, Terri [3 ]
机构
[1] Univ Cincinnati, James L Winkle Coll Pharm, Cincinnati, OH 45220 USA
[2] HOPE Ctr, Lexington, KY USA
[3] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[4] SinfoniRx, Tucson, AZ USA
来源
关键词
THERAPY MANAGEMENT SERVICES; ADHERENCE; OUTCOMES; HEALTH; CARE; HOSPITALIZATION; RECONCILIATION; ADMISSION; PROGRAM; DISEASE;
D O I
10.18553/jmcp.2015.21.5.391
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Poor medication adherence is a predictor of poor health outcomes, especially in populations with chronic diseases. Although several self-reported measures of medication adherence exist, the scope of each is limited. OBJECTIVE: To identify barriers to medication adherence in order to facilitate effective delivery of telephone-based medication therapy management (MTM) services to beneficiaries of contracted Medicare Part D plans. METHODS: This study used a cross-sectional telephone-based questionnaire designed to elicit reasons for low medication adherence. Patients were eligible to participate if they were identified as nonadherent for an antilipidemic, antihypertensive, or antidiabetic agent. Nonadherence was defined as less than 80% of proportion of days covered (PDC). The questionnaire included 17 items pertaining to medication use and 3 demographic items. Data were collected between September 2012 and February 2013. Data analyses included descriptive statistics and Rasch analyses. RESULTS: A total of 124 patients participated in the telephone survey. Of those completing the survey, the majority were patients (97.6%); only 3 surveys (2.4%) were completed by caregivers. The sample population had a mean age of 69.8 years (SD =9.9), and more than half of participants (60.4%) were female. Nineteen percent of respondents received their medications by mail. Medication nonadherence generated alerts mostly associated with antilipidemic agents (n=50, 40.3%), followed by antihypertensive drugs (n=36, 29.0%), and antidiabetic medications (n =23, 18.5%). The response categories for medication belief items were collapsed from 4 to 3 categories to achieve acceptable Rasch model fit (to fit the model and approximate interval level data). Ten percent of participants reported having medications prescribed either that they did not get or that they obtained but did not use. Almost 30% of patients reported having medications prescribed that they started using but stopped. However, only 4% of patients reporting adherence issues were related to the alert triggering for chronic medications; 96% of reports were linked to unrelated medications that did not generate an alert. The most common reason cited for medication nonadherence was experiencing side effects. CONCLUSIONS: Most participants reported positive beliefs about medications and did not report adherence issues related to those triggering alerts. MTM programs offer potential solutions to a number of barriers to medication adherence and a unique opportunity to raise awareness about the importance of medication adherence among members. Copyright (C) 2015, Academy of Managed Care Pharmacy. All rights reserved.
引用
收藏
页码:391 / 399
页数:9
相关论文
共 50 条
  • [1] Recent Medicare Part D beneficiary claims for desmopressin medications
    Johnson, Theodore M., II
    Suvada, Kara
    Plantinga, Laura C.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 (07) : 2030 - 2032
  • [2] BENEFICIARY CHOICE IN MEDICARE PART D
    King, A. J.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A83 - A83
  • [3] Development of a Medicare Beneficiary Comprehension Test: Assessing Medicare Part D Beneficiaries' Comprehension of Their Benefits
    Aruru, Meghana V.
    Salmon, J. Warren
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2013, 6 (06): : 453 - 461
  • [4] Did Medicare Part D Improve Access to Medications?
    Domino, Marisa Elena
    Farley, Joel F.
    [J]. PSYCHIATRIC SERVICES, 2010, 61 (02) : 118 - 120
  • [5] NONADHERENCE WITH ORAL HYPOGLYCEMICS AMONG MEDICARE PART D ENROLLEES WITH DIABETES
    Yang, Y.
    Thumula, V
    Pace, P. F.
    Banahan, B. F.
    Wilkin, N. E.
    Lobb, W. B.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A12 - A12
  • [6] Cost-Related Nonadherence in the Medicare Program The Impact of Part D
    Kennedy, James J.
    Maciejewski, Matthew
    Liu, Darren
    Blodgett, Elizabeth
    [J]. MEDICAL CARE, 2011, 49 (05) : 522 - 526
  • [7] Improvements in Medicare Part D Risk Adjustment Beneficiary Access and Payment Accuracy
    Kautter, John
    Ingber, Melvin
    Pope, Gregory C.
    Freeman, Sara
    [J]. MEDICAL CARE, 2012, 50 (12) : 1102 - 1108
  • [8] PREVALENCE AND COST OF MYASTHENIA GRAVIS IN THE MEDICARE BENEFICIARY SAMPLE
    Gordon, B. D.
    Noone, J. M.
    Van Doren, B. A.
    Zacherle, E.
    Blanchette, C. M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A661 - A661
  • [9] National Survey Findings of Medicare Beneficiary Perspectives of the Medicare Part D Medication Therapy Management Standardized Format
    Cooke, C.
    Sharma, K.
    Chou, J.
    Pellegrin, K.
    Brandt, N.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S249 - S249
  • [10] Reasons for nonadherence to medications among African American patients with hypertension
    Ogedegbe, GO
    Allegrante, J
    Mancuso, C
    Charlson, M
    [J]. PSYCHOSOMATIC MEDICINE, 2000, 62 (01) : 111 - 111